DF
MRK icon

Donoghue Forlines’s Merck MRK Stock Holding History

Donoghue Forlines’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.57M Buy
29,649
+14,417
+95% +$1.66M 0.99% 18
2025
Q4 		$1.6M Sell
15,232
-2,467
-14% -$232K 0.5% 60
2025
Q3 		$1.49M Sell
17,699
-642
-4% -$52.9K 0.46% 83
2025
Q2 		$1.45M Buy
18,341
+2,755
+18% +$219K 0.41% 89
2025
Q1 		$1.4M Buy
+15,586
New +$1.46M 0.44% 100
2024
Q3 		– Sell
-15,389
Closed -$1.91M – 265
2024
Q2 		$1.91M Buy
15,389
+17
+0.1% +$2.19K 0.54% 33
2024
Q1 		$2.03M Buy
15,372
+626
+4% +$77.2K 0.58% 34
2023
Q4 		$1.61M Sell
14,746
-939
-6% -$97.5K 0.5% 40
2023
Q3 		$1.61M Buy
15,685
+1,253
+9% +$135K 0.57% 32
2023
Q2 		$1.67M Sell
14,432
-5,916
-29% -$672K 0.52% 36
2023
Q1 		$2.16M Sell
20,348
-5,811
-22% -$627K 0.78% 17
2022
Q4 		$2.9M Buy
26,159
+12,654
+94% +$1.29M 1.03% 14
2022
Q3 		$1.16M Sell
13,505
-7,298
-35% -$651K 0.42% 23
2022
Q2 		$1.9M Sell
20,803
-2,874
-12% -$255K 0.5% 28
2022
Q1 		$1.94M Sell
23,677
-6,293
-21% -$496K 0.42% 45
2021
Q4 		$2.3M Buy
+29,970
New +$2.39M 0.39% 46
2020
Q4 		– Sell
-14,708
Closed -$1.16M – 281
2020
Q3 		$1.16M Buy
+14,708
New +$1.15M 0.32% 94
2020
Q2 		– Sell
-10,388
Closed -$763K – 86
2020
Q1 		$763K Sell
10,388
-28,171
-73% -$2.21M 0.17% 23
2019
Q4 		$3.35M Buy
+38,559
New +$3.17M 0.52% 44
2018
Q4 		– Sell
-201,740
Closed -$13.7M – 104
2018
Q3 		$13.7M Sell
201,740
-68,419
-25% -$4.36M 1.07% 36
2018
Q2 		$15.6M Sell
270,159
-69,944
-21% -$3.95M 1.29% 39
2018
Q1 		$17.7M Buy
340,103
+4,505
+1% +$243K 1.53% 18
2017
Q4 		$18M Buy
335,598
+72,126
+27% +$4M 1.36% 32
2017
Q3 		$16.1M Buy
263,472
+1,354
+0.5% +$82.1K 1.7% 39
2017
Q2 		$16M Buy
+262,118
New +$16M 1.82% 28

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Donoghue Forlines's MRK Position: Q1 2026 in Review

Donoghue Forlines increased its Merck (MRK) stake by 95% in Q1 2026, buying an estimated $1.66M and bringing the position to 29,649 shares worth $3.57M. The position accounts for 0.99% of the portfolio, ranked #18.

Donoghue Forlines first reported a position in MRK in Q2 2017 and has held it in 25 quarters since. The position peaked at $18M in Q4 2017. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Donoghue Forlines held 29,649 shares of Merck worth $3.57M as of Q1 2026.
  • Donoghue Forlines bought 14,417 Merck shares in Q1 2026, an estimated $1.66M.
  • Merck made up 0.99% of Donoghue Forlines's portfolio in Q1 2026, its #18 holding.
  • Donoghue Forlines first reported a position in Merck in Q2 2017 and has held it in 25 quarters since.
  • Donoghue Forlines's Merck position peaked at $18M in Q4 2017.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Donoghue Forlines's 13F filing for Q1 2026, filed 13 May 2026.